BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6512 related articles for article (PubMed ID: 3516075)

  • 1. [Distribution of BCG antigens in mouse-tumor cells].
    Sasaki J; Sawamura D; Kamiya S; Yamatani S; Satoh K; Fukushi K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1074-6. PubMed ID: 3516075
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
    Bucana C; Hanna MG
    J Natl Cancer Inst; 1974 Nov; 53(5):1313-23. PubMed ID: 4139279
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis.
    Bartlett GL; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1972 Jan; 48(1):245-57. PubMed ID: 4568964
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancing effect of coenzyme, Q10 on immunorestoration with Mycobacterium bovis BCG in tumor-bearing mice.
    Kawase I; Niitani H; Saijo N; Sasaki H; Morita T
    Gan; 1978 Aug; 69(4):493-7. PubMed ID: 101414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells.
    Meltzer MS; Bartlett GL
    J Natl Cancer Inst; 1972 Nov; 49(5):1439-43. PubMed ID: 4568090
    [No Abstract]   [Full Text] [Related]  

  • 9. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 10. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    Minden P; McClatchy JK; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
    [No Abstract]   [Full Text] [Related]  

  • 11. [Shared antigens between BCG and tumor cells--immunotherapy with BCG for mouse tumor].
    Sasaki J; Kanda S; Sawamura D; Kamiya S; Inaba Y; Kawashima M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1432-9. PubMed ID: 4015119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution of human alpha-fetoprotein in animal tumor cells].
    Sasaki J; Rafigul AC; Lü CL; Tamagake T
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3305-8. PubMed ID: 2461682
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.
    Tarrant JP; Walsh MJ; Blanchard MC; Lee TD; Hoskin DW; Giacomantonio CA
    Int J Oncol; 2004 Dec; 25(6):1693-9. PubMed ID: 15547707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of common sarcoma-associated antigen(s) in an established human neurogenic sarcoma cell line.
    Drewinko B; Montgomery CT; Trujillo JM
    Cancer Res; 1973 Mar; 33(3):601-5. PubMed ID: 4347719
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 16. Some aspects of the cellular and humoral immune response to tumour antigens.
    Hellström KE; Hellström I
    Triangle; 1972; 11(1):23-8. PubMed ID: 4624858
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D; Jeannin JF; Martin F
    C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigens common to Mycobacterium bovis (BTsZh) and several malignant and normal tissues of laboratory animals].
    Lomakin MS; Maĭskiĭ IN; Mamaeva TN; Larin AS; Levitina VL
    Biull Eksp Biol Med; 1977 Jan; 83(1):65-8. PubMed ID: 403974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Definition of tumor-necrosis factor and its production mechanism].
    Urushizaki I; Niitsu Y; Watanabe N
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1356-68. PubMed ID: 6378100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic analysis between BCG and tumor cells by BCG-monoclonal antibodies.
    Sasaki J; Kitagawa M; Tamagake T; Narita S; Ahsan CR; Lu CL
    Microbiol Immunol; 1989; 33(11):951-5. PubMed ID: 2687649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 326.